Medgenics, Inc.

Medgenics, Inc.

Sector: Pharmaceutical Preparations Region: PA, United States

: | OTC Markets: MDGWW | London Stock Exchange: MEDG | NYSE MKT: MDGN | NYSE MKT: MDGN.WT | London Stock Exchange: MEDU

Similar to: NPS Pharmaceuticals, Inc., Sareum Holdings Plc, AstraZeneca Plc

Medgenics, Inc. is a medical technology and therapeutics company, which develops protein therapeutics medical therapies. It develops Biopump technology which is used for the treatment of a range of chronic diseases and its product pipeline includes Epodure, Infradure and Hemodure The Company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in San Francisco, CA.

News & Analysis

You may also be interested in: